Birdwatch Note
2024-05-17 14:59:12 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
事実無根のデマです。 ツイートは、イベルメクチンやヒドロキシクロロキンがコロナウイルスを「追い払う」効果があり、それが「ウイルスをばら撒いた勢力」にとって都合が悪かったと主張していますが、この主張を裏付ける根拠はありません。 実際には、複数の大規模臨床試験の結果、これら2つの薬剤にコロナウイルス感染症の治療効果はないことが確認されています。 ■イベルメクチン コロナ治療薬の承認申請を断念 有効性見られず https://www.google.com/amp/s/www3.nhk.or.jp/news/html/20220926/amp/k10013838301000.html ■新型コロナウイルス感染症の入院患者におけるヒドロキシクロロキンの影響 https://www.nejm.org/doi/full/10.1056/NEJMoa2022926
Written by 600FD0363C54FF998A92BA8063786EDEE94D51BFDDDA7E4B6EB475D435244AD2
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1791474885883232387
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1791483615098102039
- noteId - 1791483615098102039
- participantId -
- noteAuthorParticipantId - 600FD0363C54FF998A92BA8063786EDEE94D51BFDDDA7E4B6EB475D435244AD2 Participant Details
- createdAtMillis - 1715957952652
- tweetId - 1791474885883232387
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 事実無根のデマです。 ツイートは、イベルメクチンやヒドロキシクロロキンがコロナウイルスを「追い払う」効果があり、それが「ウイルスをばら撒いた勢力」にとって都合が悪かったと主張していますが、この主張を裏付ける根拠はありません。 実際には、複数の大規模臨床試験の結果、これら2つの薬剤にコロナウイルス感染症の治療効果はないことが確認されています。 ■イベルメクチン コロナ治療薬の承認申請を断念 有効性見られず https://www.google.com/amp/s/www3.nhk.or.jp/news/html/20220926/amp/k10013838301000.html ■新型コロナウイルス感染症の入院患者におけるヒドロキシクロロキンの影響 https://www.nejm.org/doi/full/10.1056/NEJMoa2022926
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-05-17 14:59:12 UTC (1715957952652) |
2024-05-17 22:00:36 UTC (1715983236131) |
CURRENTLY_RATED_HELPFUL | 2024-05-20 02:18:08 UTC (1716171488374) |
CURRENTLY_RATED_HELPFUL | 2024-05-17 22:00:36 UTC (1715983236131) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-05-19 02:39:10 -0500 | Rating Details | |
2024-05-18 19:30:08 -0500 | Rating Details | |
2024-05-18 19:19:47 -0500 | Rating Details | |
2024-05-18 19:19:20 -0500 | Rating Details | |
2024-05-18 09:11:03 -0500 | Rating Details | |
2024-05-17 23:26:10 -0500 | Rating Details | |
2024-05-17 22:32:33 -0500 | Rating Details | |
2024-05-17 22:24:43 -0500 | Rating Details | |
2024-05-17 11:26:27 -0500 | Rating Details | |
2024-05-17 11:02:05 -0500 | Rating Details | |
2024-05-17 10:45:35 -0500 | Rating Details | |
2024-05-17 10:43:20 -0500 | Rating Details | |
2024-05-17 10:37:22 -0500 | Rating Details | |
2024-05-17 10:29:23 -0500 | Rating Details | |
2024-05-17 10:12:10 -0500 | Rating Details | |
2024-05-17 10:07:13 -0500 | Rating Details | |
2024-05-17 10:07:06 -0500 | Rating Details | |
2024-05-19 08:09:07 -0500 | Rating Details | |
2024-05-18 19:45:19 -0500 | Rating Details | |
2024-05-18 19:19:52 -0500 | Rating Details | |
2024-05-18 19:19:26 -0500 | Rating Details | |
2024-05-18 10:30:54 -0500 | Rating Details | |
2024-05-18 07:09:02 -0500 | Rating Details | |
2024-05-18 07:00:41 -0500 | Rating Details | |
2024-05-18 01:31:55 -0500 | Rating Details | |
2024-05-17 15:34:19 -0500 | Rating Details | |
2024-05-17 15:29:23 -0500 | Rating Details | |
2024-05-17 15:02:19 -0500 | Rating Details | |
2024-05-17 12:47:14 -0500 | Rating Details | |
2024-05-17 10:28:07 -0500 | Rating Details | |
2024-05-17 10:13:20 -0500 | Rating Details | |
2024-05-19 20:56:22 -0500 | Rating Details | |
2024-05-17 21:30:41 -0500 | Rating Details | |
2024-05-17 17:34:36 -0500 | Rating Details | |
2024-05-17 16:45:54 -0500 | Rating Details | |
2024-05-17 16:37:31 -0500 | Rating Details | |
2024-05-17 15:24:11 -0500 | Rating Details | |
2024-05-17 14:49:11 -0500 | Rating Details | |
2024-05-17 14:41:18 -0500 | Rating Details | |
2024-05-17 13:02:28 -0500 | Rating Details | |
2024-05-17 11:10:39 -0500 | Rating Details | |
2024-05-17 11:00:49 -0500 | Rating Details | |
2024-05-17 10:44:11 -0500 | Rating Details | |
2024-05-17 10:11:49 -0500 | Rating Details | |
2024-05-17 10:08:48 -0500 | Rating Details | |
2024-05-19 17:17:01 -0500 | Rating Details | |
2024-05-19 18:11:20 -0500 | Rating Details | |
2024-05-18 19:27:19 -0500 | Rating Details | |
2024-05-18 19:21:18 -0500 | Rating Details | |
2024-05-18 19:19:31 -0500 | Rating Details | |
2024-05-18 19:17:32 -0500 | Rating Details | |
2024-05-18 15:26:13 -0500 | Rating Details | |
2024-05-18 03:14:40 -0500 | Rating Details | |
2024-05-17 11:59:14 -0500 | Rating Details | |
2024-05-17 11:34:32 -0500 | Rating Details | |
2024-05-17 10:40:24 -0500 | Rating Details | |
2024-05-17 10:36:56 -0500 | Rating Details | |
2024-05-17 10:24:43 -0500 | Rating Details | |
2024-05-17 10:23:37 -0500 | Rating Details | |
2024-05-17 10:14:05 -0500 | Rating Details | |
2024-05-17 10:03:12 -0500 | Rating Details | |
2024-05-18 19:37:26 -0500 | Rating Details | |
2024-05-17 22:36:12 -0500 | Rating Details |